Home
StockRanks™
Platform
Insights
Research & Discuss
Editorial & Community
Learn & Improve
Webinars & Masterclasses
Stockopedia Academy
Reviews
Pricing
Get started
Log in
Sectors
Healthcare
Biotechnology & Medical Research
Cullinan Therapeutics
CGEM —
Cullinan Therapeutics
News Story
$14.92
0.00
0.00%
Last trade -
00:00
Healthcare
Adventurous
Mid Cap
Neutral
Market Cap
$960.17m
Enterprise Value
$625.63m
Revenue
Quality
Value
Momentum
Stock
Rank
™
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
CGEM Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
CGEM Dividends
All News
Brief: Cullinan Oncology Q2 Adjusted Net Income USD -32.2 Million
Cullinan Therapeutics
10/08/2023 12:00
Aug 10 (Reuters) - Cullinan Oncology Q2 cash & investments USD 512.1 million
Recent news on Cullinan Therapeutics
See all news
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
13/08/2026 18:46
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
13/08/2026 17:18
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
13/08/2026 14:39
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies
13/08/2026 12:56
Cullinan climbs as lung cancer drug meets late-stage trial goal
13/08/2026 10:39